- Asahi Kasei Elevates Critical Care Solutions with FDA Approval of ZOLL’s Zenix Monitor/Defibrillator
- Field Medical | First-in-Human 6-Month Data Selected for Late-Breaking Clinical Trial at VT Symposium 2025
- Summit Cancer Center Director, Arvind Chaudhry, MD, PhD, to Chair Coeur d’Alene Hematology Oncology Conference Focused on Precision-Guided Cancer Care
- Italfarmaco Appoints Francesco Di Marco as CEO
- Santhera Secures Agreement with Biomedica for the Distribution of AGAMREE® (Vamorolone) in Russia
- Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy for ZI-MA4-1 Paving the Way for First-in-Human Trials in the UK
- Tensive publishes positive long-term clinical follow-up data in Breast Cancer on REGENERA™ / SOFTAG™ breast implant
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States
Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!
“Medical Device News: Essential Key Insights and Noteworthy Developments Shaping the Future”
How To Draw Customers to Your Trade Show Booth
Steps to take to draw customers in
Prinses Máxima Center for Pediatric Oncology Implements Callisto™ from Volta Labs to Streamline Clinical Genomics Workflows
The Prinses Máxima Center is the largest pediatric cancer center in Europe, dedicated to integrating care and research to improve outcomes for children with cancer
‘CART BP pro’ Opens a New Paradigm in Blood Pressure Management, Maintaining Accuracy Across Arm Positions
The device demonstrated consistent accuracy even when the arm was positioned below heart level, meeting the rigorous validation requirements set by the European Society of Hypertension (ESH).
MDI Health and Stanford Medicine’s Healthcare AI Applied Research Team (HEA₃RT) Launch Research Collaboration on AI-Powered Medication Management Intelligence
Pioneering study aims to demonstrate the robustness of personalized medication analysis and recommendations for polypharmacy patients generated by MDI Health’s novel Artificial Pharmacology Intelligence (API).
Clinical Trials
PhotoniCare’s OtoSight Demonstrates More Accurate Diagnosis and a 50 Percent Reduction in Antibiotic Usage for Pediatric Ear Infections in Large Randomized Controlled Trial
The results of the study, Otitis Treatment with OtoSight™ – Modification of Antibiotic Treatment Intervention in Children (OTO-MATIC), have been published via open access in the International Journal of Pediatric Otorhinolaryngology.
Schreiner MediPharm Introduces Smart Syringe Box for Tracking in Clinical Trials
Solution provides intelligent packaging for precise therapy monitoring of syringes used in clinical trials.
Phenomix and Mayo Clinic Publish Research Demonstrating Utility of MyPhenome Test for Personalized GLP-1 and Phen-Top Treatment
Published in Cell Metabolism, the Phenomix and Mayo Clinic research shows the MyPhenomeTM test can help providers guide obesity treatment by matching patients to GLP-1s or phentermine/topiramate based on their unique biology.
Biotechnology News
ACIP Recommends Use of Merck’s ENFLONSIA for Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season
ENFLONSIA is the first and only RSV preventive option for administration to infants using the same dose regardless of weight. Ordering will begin in July, with shipments delivered before the start of the 2025-2026 RSV season
Breakthrough in Patient-Derived Stem Cells for Therapeutic Regenerative Medicine
These studies shed light on the scientific controversy of whether activation of the Wnt/β-catenin pathway induces human stem cell pluripotency or differentiation.
Alithea Genomics Launches MERCURIUS™ Total DRUG-seq: A Next-Generation Full-Length Transcriptome Profiling Platform for High-Throughput Compound Screening and Target Validation
“MERCURIUS™ Total DRUG-seq represents a new frontier in transcriptome-scale compound screening,” said Riccardo Dainese, CEO and Co-founder of Alithea Genomics. “We are empowering scientists to capture the full complexity of transcriptional responses—at a massive scale and with minimal cost. This product opens the door to discovering new biology, new targets, and new drugs faster than ever before.”
Our Experts – Byline Articles
Read Their Views & Share With a Colleague or Two!
5 Trends Shaping the IPO Market: Health to Fintech in 2025 | By Jack Horton
Jack Horton is a market analyst and tech industry researcher specializing in global IPO trends, emerging fintech ecosystems, and digital health innovation
Skin May Become the First Organ to Fulfill the Promise of Regenerative Medicine | By Dr. Ned Swanson – President & Chief Medical Officer of PolarityBio
The field of regenerative medicine may be on the cusp of an evolution, and due to the unique attributes of skin and wounds, the largest organ in the body may be emerging as a leader
Pinpointing the Invisible Source of Chronic Low Back Pain | By Brent Ness, CEO of Aclarion
Intense chronic low back pain (CLBP) is a global epidemic that plagues over 266 million people worldwide – we are not referring to the kind of sore back that you have after a long flight or weekend sleeping on your friend’s sofa, but rather the grinding, “drops you to your knees” pain that prevents you from going to work or school
FDA Medical Device Updates
Mursla Bio Receives FDA Breakthrough Device Designation for EvoLiver Test
Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients
Nanox Receives FDA Clearance for General Use of New Imaging System, Nanox.ARC X
First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indications. The enhanced imaging system features sleek design with smaller footprint; simplified ‘plug and play’ installation process and the system design enables software upgrades and new capabilities to be added remotely following future regulatory clearances
Medline Announces FDA Clearance for REFLEX HYBRID Nitinol Implants for Foot and Ankle Surgery
“REFLEX HYBRID further demonstrates our commitment to offering innovative solutions for foot and ankle surgeons. The first to market product addresses gaps in the current competitive landscape, including offering indication specific designs, intraoperative compression, and intraoperative adjustment with a nitinol implant,” said Scott Goldstein, vice president of product management for Medline UNITE.
Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding
Intensity Therapeutics, Inc. Announces $2.35 Million Public Offering
The Series B-1 warrants will have an exercise price of $0.85 per share, will be immediately exercisable and will expire 5 years from issuance. The Series B-2 warrants will have an exercise price of $0.85 per share, will be immediately exercisable and will expire 18 months from issuance.
Overture Life Secures $57M in Total Funding | Earns U.S. CLIA License to Deliver Reliable, Scalable IVF Automation
Overwater Ventures, GV, and Khosla Ventures invest in a rigorous clinical approach that raises throughput for fertility clinics, expands access, and empowers women to plan on their own terms.
Cofertility Closes Series A Funding, Led by Next Ventures and Offline Ventures, to Revolutionize Fertility and Family Building
The funding will be primarily used towards the further development of Cofertility’s proprietary, user-friendly technology platform, a custom-built egg donor database that streamlines the entire egg donation process, from recruitment and matching to cycle coordination. Already this technology has helped improve the Cofertility experience for its members.
Phantom Neuro Secures $19M Series A Funding
Investment will accelerate clinical trials and commercialization of Phantom X, with Ottobock joining Phantom Neuro’s Board of Directors
Market Reports
Advancements in Imaging
Subtle Medical Reports: SubtleHD™ Awarded FDA Clearance, Setting a New Benchmark for MRI Image Quality and Speed
With FDA clearance of SubtleHD™, Subtle Medical launches Subtle-ELITE™, an industry-first AI package designed to achieve superior image quality, unprecedented speed, and workflow automation.
Philips, World Bank, and Ukraine Ministry of Health Announce Successful Deployment of Nationwide Acute Stroke Care Upgrade, Helping Thousands of Patients
“This program is saving lives, reducing disability, and changing the futures of stroke patients,” said Dr. Dmytro Lebedynets, a neurologist at Feofaniya Clinical Hospital and consultant on stroke to the World Bank and the Ministry of Health of Ukraine. “With these advanced tools, we can deliver timely and precise life-saving care, even in emergencies. It’s a game-changer for our patients. Now all the regions of our country will be able to provide the full spectrum of care to stroke patients.”
Philips and AWS Expand Strategic Collaboration to Advance HealthSuite Cloud Services and Power Generative AI Workflows
“The collaboration between Philips and AWS gives healthcare providers scalable, secure-by-design cloud-enabled solutions to accelerate healthcare innovation,” said Matt Garman, CEO of AWS. “Combining Philips’ healthcare informatics portfolio with AWS generative AI capabilities gives clinicians access to imaging insights so they can deliver more effective and efficient care to patients anywhere, anytime, with best-in-class security and privacy.”
Hospitals In the News
Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry
Non-Profit News
Healthcare - Understanding the Business Side of the Industry and Its Implications
How Individual Coverage Health Reimbursement Arrangements Are Changing Health Benefits
Many employers researching innovative ways to redesign their benefits programs are now looking into ADP’s plans and similar offerings to see how they can deliver a personalized experience without sacrificing business stability.
The EHR + RCM Combo That Mental Health Practices Have Been Waiting For
Integrating EHR and RCM systems created for mental health isn’t just a step up on technology—it is also rethinking care and administration coming together.
How ABA Billing Services Drive a Healthier Revenue Cycle for Therapy Practices
In ABA therapy, delivering quality care is the goal—but sustaining that care depends on something just as critical: a steady, healthy revenue cycle.
Building Better Care: How Healthcare Facilities Can Support Disability Needs
As the healthcare landscape shifts to better meet the needs of a diverse population, qualified providers are essential to ensuring that these needs are met.
Healthcare Careers
Nurses Corner
Press Ganey Streamlines Magnet® Readiness with AI
“Nurses play a crucial role in healthcare, and supporting their vital contributions is our highest priority,” said Jeff Doucette, DNP, RN, NEA-BC, FACHE, FAAN, Chief Nursing Officer at Press Ganey. “Nursing Intelligence speeds up and simplifies the reporting and benchmarking processes, providing nurse leaders with the insights needed for informed decision-making and enhanced care delivery.”
Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
Compounded GLP-1 injections are fulfilled and shipped from Hims & Hers’ affiliated pharmacies. The treatments customers receive from Hims & Hers will always come from a state-licensed, FDA-regulated facility. The company maintains high standards of safety and quality in their ingredients and transparency in operations.
U.S. Nursing Care Focused Insights Report 2024-2029
The U.S. nursing care market was valued at USD 475.15 billion in 2023 and is expected to reach a value of $692.19 billion by 2029, growing at a CAGR of 6.47% from 2023 to 2029.
